» Articles » PMID: 33581098

COVID-19 and Unilateral Withdrawal of Life-Sustaining Treatments: Tragedy in Crisis, and Lessons for Everyday Medicine

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2021 Feb 13
PMID 33581098
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Clinical Characteristics and Prognosis of Older Patients with Coronavirus Disease 2019 Requiring Mechanical Ventilation.

Hong G, Kang D, Park S, Lee S, Park O, Kim T J Pers Med. 2024; 14(6).

PMID: 38929878 PMC: 11204506. DOI: 10.3390/jpm14060657.


D-dimer, BNP/NT-pro-BNP, and creatinine are reliable decision-making biomarkers in life-sustaining therapies withholding and withdrawing during COVID-19 outbreak.

Smadja D, Fellous B, Bonnet G, Hauw-Berlemont C, Sutter W, Beauvais A Front Cardiovasc Med. 2022; 9:935333.

PMID: 36148049 PMC: 9485619. DOI: 10.3389/fcvm.2022.935333.

References
1.
Eberl J . Ethics as Usual? Unilateral Withdrawal of Treatment in a State of Exception. Am J Bioeth. 2020; 20(7):210-211. DOI: 10.1080/15265161.2020.1779401. View

2.
Sulmasy D, Maldonado F . COUNTERPOINT: Is It Ethically Permissible to Unilaterally Withdraw Life-Sustaining Treatments for Reallocation During Crisis Standards of Care? No. Chest. 2021; 159(6):2167-2169. DOI: 10.1016/j.chest.2021.01.032. View

3.
Bishop J, Eberl J . POINT: Is It Ethically Permissible to Unilaterally Withdraw Life-Sustaining Treatments During Crisis Standards of Care? Yes. Chest. 2021; 159(6):2165-2166. DOI: 10.1016/j.chest.2021.01.029. View